UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors

Group 1: Company Performance - UnitedHealth Group (UNH) closed at $307.70, with a daily increase of +1.31%, outperforming the S&P 500's loss of 0.07% [1] - Over the past month, shares of UnitedHealth Group have appreciated by 0.17%, while the Medical sector experienced a loss of 1.3% [1] Group 2: Upcoming Earnings - The earnings report for UnitedHealth Group is scheduled for July 29, 2025, with expected earnings of $5.08 per share, reflecting a year-over-year decline of 25.29% [2] - Revenue is forecasted to be $111.86 billion, indicating a growth of 13.16% compared to the same quarter last year [2] Group 3: Annual Estimates - For the annual period, earnings are anticipated to be $21.85 per share, with revenue projected at $449.46 billion, representing declines of -21.01% and growth of +12.29%, respectively [3] Group 4: Analyst Estimates - Recent modifications to analyst estimates for UnitedHealth Group reflect evolving short-term business trends, with positive revisions indicating analyst optimism [4] - The Zacks Rank system, which incorporates estimate changes, provides a rating system for investors [5] Group 5: Zacks Rank and Valuation - UnitedHealth Group currently holds a Zacks Rank of 5 (Strong Sell), with the consensus EPS estimate moving 2.81% lower over the last 30 days [6] - The company has a Forward P/E ratio of 13.9, which is a premium compared to the industry average of 13.02, and a PEG ratio of 1.45, compared to the industry average of 0.86 [7] Group 6: Industry Overview - The Medical - HMOs industry, part of the Medical sector, has a Zacks Industry Rank of 91, placing it in the top 37% of over 250 industries [8]